Literature DB >> 17966968

Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in women.

Irene F Gazi1, Haralampos J Milionis, Theodosios D Filippatos, Vasilis Tsimihodimos, Michael S Kostapanos, Michael Doumas, Alexandros D Tselepis, Moses Elisaf.   

Abstract

BACKGROUND: To assess the metabolic profile and the prevalence of the metabolic triad (i.e. hyperinsulinaemia, hyperapobetalipoproteinaemia, and decreased low-density lipoprotein particle size) in women characterized by the hypertriglyceridaemic waist (HTGW) phenotype and to identify cut-off values for triglycerides and waist circumference, effectively discriminating women with the metabolic triad.
METHODS: Two hundred and twenty-eight female subjects without any history of vascular disease or diabetes mellitus attending an Outpatient Lipid Clinic setting at the University Hospital of Ioannina, Greece were studied.
RESULTS: Currently available HTGW criteria for women were unable to detect any significant differences in the metabolic profile either in the pre- or post-menopausal women, and proved similar in terms of sensitivity and specificity in identifying women with the metabolic triad. A cut-off value of 1.26 mmol/L for triglycerides and 84.5 cm for waist circumference were determined by Receiver-operating Curve evaluation. Women with both triglycerides and waist circumference above these thresholds had four-fold higher odds of presenting with the metabolic triad compared with women with non-HTGW phenotype.
CONCLUSIONS: A HTGW phenotype definition of 1.26 mmol/L for triglycerides and 84.5 cm for waist circumference may effectively identify Mediterranean women with the atherogenic metabolic triad. Whether these criteria are also associated with a higher incidence of vascular disease and/or new-onset diabetes in women remains to be investigated. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17966968     DOI: 10.1002/dmrr.784

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  4 in total

1.  Rationale, design and baseline patient characteristics of the optimal type 2 diabetes management including benchmarking and standard treatment study in Greece.

Authors:  Michael S Kostapanos; Vasilis Tsimihodimos; Moses S Elisaf; Emmanouil Tzouvelekis; Nikos Nikas
Journal:  World J Diabetes       Date:  2014-02-15

Review 2.  Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?

Authors:  Aris P Agouridis; Christos V Rizos; Moses S Elisaf; Theodosios D Filippatos
Journal:  Rev Diabet Stud       Date:  2013-08-10

3.  Hypertriglyceridemic waist phenotype and abnormal glucose metabolism: a system review and meta-analysis.

Authors:  Chun-Ming Ma; Xiao-Li Liu; Na Lu; Rui Wang; Qiang Lu; Fu-Zai Yin
Journal:  Endocrine       Date:  2019-05-07       Impact factor: 3.633

4.  Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients.

Authors:  Sunghwan Suh; Hyung-Doo Park; Se Won Kim; Ji Cheol Bae; Alice Hyun-Kyung Tan; Hye Soo Chung; Kyu Yeon Hur; Jae Hyeon Kim; Kwang-Won Kim; Moon-Kyu Lee
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.